CALR and cancer: Interestingly, a recent study elaborated that tumors release a soluble CALR [127] that acts as a decoy for CALR receptors in phagocytes inhibiting the uptake of dying cancer cells leading to the accumulation of immunosuppressive cells in peripheral blood [128], immune evasion [129], and resistance to PD-1/PD-L1 blockade [127].